Why C.H. Robinson (CHRW) is Poised to Beat Earnings Estimates Again — Positive
CHRW Zacks Investment Research — July 03, 2025C.H. Robinson (CHRW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will KeyCorp (KEY) Beat Estimates Again in Its Next Earnings Report? — Positive
KEY Zacks Investment Research — July 03, 2025KeyCorp (KEY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will FMC (FMC) Beat Estimates Again in Its Next Earnings Report? — Positive
FMC Zacks Investment Research — July 03, 2025FMC (FMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
REE Automotive Receives Nasdaq Minimum Bid Price Notification — Neutral
REE GlobeNewsWire — July 03, 2025TEL AVIV, Israel, July 03, 2025 (GLOBE NEWSWIRE) -- REE Automotive Ltd. (“REE” or the “Company”) (Nasdaq: REE), an automotive technology company that develops software-defined vehicle (SDV) technology solutions, today reported that the Company received a letter (the “Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is currently not in compliance with Nasdaq Rule 5450(a)(1). In particular, the Letter stated that the Company's closing bid price for its Class A ordinary shares (the “Ordinary Shares”) has been below $1.00 per share for the last 30 consecutive business days beginning on May 15, 2025 through June 27, …
Are You Looking for a Top Momentum Pick? Why Fulton Financial (FULT) is a Great Choice — Positive
FULT Zacks Investment Research — July 03, 2025Does Fulton Financial (FULT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You Looking for a Top Momentum Pick? Why Shore Bancshares (SHBI) is a Great Choice — Positive
SHBI Zacks Investment Research — July 03, 2025Does Shore Bancshares (SHBI) have what it takes to be a top stock pick for momentum investors? Let's find out.
HNI (HNI) Is Up 6.94% in One Week: What You Should Know — Positive
HNI Zacks Investment Research — July 03, 2025Does HNI (HNI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Primoris Services (PRIM) Is Up 8.18% in One Week: What You Should Know — Positive
PRIM Zacks Investment Research — July 03, 2025Does Primoris Services (PRIM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You Looking for a Top Momentum Pick? Why Univest (UVSP) is a Great Choice — Positive
UVSP Zacks Investment Research — July 03, 2025Does Univest (UVSP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Bilibili (BILI) is a Great Momentum Stock: Should You Buy? — Positive
BILI Zacks Investment Research — July 03, 2025Does Bilibili (BILI) have what it takes to be a top stock pick for momentum investors? Let's find out.
WisdomTree, Inc. (WT) is a Great Momentum Stock: Should You Buy? — Positive
WT Zacks Investment Research — July 03, 2025Does WisdomTree, Inc. (WT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Acadian Asset Management (AAMI) is a Great Momentum Stock: Should You Buy? — Positive
AAMI Zacks Investment Research — July 03, 2025Does Acadian Asset Management (AAMI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Flex (FLEX) Is Up 8.39% in One Week: What You Should Know — Positive
FLEX Zacks Investment Research — July 03, 2025Does Flex (FLEX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Hims & Hers Enhances Healthcare Through AI-Driven Personalization — Positive
HIMS Zacks Investment Research — July 03, 2025HIMS taps AI and $870 million in funding to deliver smarter, more personalized healthcare through tech-driven innovation.
My Top Near 10% Yield Pick For July 2025: Western Midstream — Positive
WES Seeking Alpha — July 03, 202510% yields tend to be high risk, slow growth, or both. However, there is a 10% yield right now that is low risk and offers inflation-beating growth potential. I detail my top 10%-yielding pick of the moment.
Gencor Stock Dips After Q4 Earnings Despite Full-Year Revenue Gain — Neutral
GENC Zacks Investment Research — July 03, 2025GENC posts 7.7% revenue growth in fiscal 2024 as higher equipment and parts sales offset fiscal fourth quarter margin and income declines.
Actelis Networks Announces Closing of Private Placement Priced At-the-Market under Nasdaq Rules — Neutral
ASNS GlobeNewsWire — July 03, 2025FREMONT, Calif, July 03, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the issuance and sale of 1,626,019 shares of its common stock, Series A-3 warrants to purchase up to an aggregate of 1,626,019 shares of common stock and short-term Series A-4 warrants to purchase up to an aggregate of 3,252,038 shares of common stock, at a purchase price of $0.615 per share and associated …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) — Neutral
TSHA GlobeNewsWire — July 03, 2025DALLAS, July 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on July 1, 2025, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, options to purchase 30,000 shares of the Company's common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) — Neutral
FATE GlobeNewsWire — July 03, 2025SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on July 2, 2025 the Company granted (i) non-qualified stock options to one newly-hired non-executive employee to purchase a total of 30,000 shares of the Company's common stock at an exercise price per share of $1.12, which was the closing price per share of the Company's common stock as reported by NASDAQ on July 2, 2025, the options grant …
ROSEN, LEADING INVESTOR COUNSEL, Encourages Petco Health and Wellness Company, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WOOF — Neutral
WOOF GlobeNewsWire — July 03, 2025NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) between January 14, 2021 and June 5, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 29, 2025.
